Fmoc/Boc protected amino acids market projected to reach $756 million by 2032

The global market for Fmoc/Boc protected amino acids is expected to grow significantly, rising from an estimated $399 million in 2025 to $756 million by 2032. According to a report by YH Research, the sector is projected to maintain a compound annual growth rate (CAGR) of 9.6 percent between 2026 and 2032.

Growth is driven by the expanding research, development, and commercial production of peptide drugs, particularly in the fields of cancer and metabolic diseases. The increasing use of non-natural and modified amino acids, alongside expanded production capacities by Contract Development and Manufacturing Organizations (CDMOs), further supports this upward trend.

Major industry players are increasing investments in peptide manufacturing infrastructure. In the United States, SK pharmteco has announced plans to invest over $200 million over five years to enhance small molecule and peptide manufacturing capabilities. Similarly, CordenPharma has begun a $200 million expansion of its peptide manufacturing facility in South Carolina.